Literature DB >> 23482328

Tissue- and cell-specific co-localization of intracellular gelatinolytic activity and matrix metalloproteinase 2.

Ann Iren Solli1, Bodil Fadnes, Jan-Olof Winberg, Lars Uhlin-Hansen, Elin Hadler-Olsen.   

Abstract

Matrix metalloproteinase 2 (MMP-2) is a proteolytic enzyme that degrades extracellular matrix proteins. Recent studies indicate that MMP-2 also has a role in intracellular proteolysis during various pathological conditions, such as ischemic injuries in heart and brain and in tumor growth. The present study was performed to map the distribution of intracellular MMP-2 activity in various mouse tissues and cells under physiological conditions. Samples from normal brain, heart, lung, liver, spleen, pancreas, kidney, adrenal gland, thyroid gland, gonads, oral mucosa, salivary glands, esophagus, intestines, and skin were subjected to high-resolution in situ gelatin zymography and immunohistochemical staining. In hepatocytes, cardiac myocytes, kidney tubuli cells, epithelial cells in the oral mucosa as well as in excretory ducts of salivary glands, and adrenal cortical cells, we found strong intracellular gelatinolytic activity that was significantly reduced by the metalloprotease inhibitor EDTA but not by the cysteine protease inhibitor E-64. Furthermore, the gelatinolytic activity was co-localized with MMP-2. Western blotting and electron microscopy combined with immunogold labeling revealed the presence of MMP-2 in different intracellular compartments of isolated hepatocytes. Our results indicate that MMP-2 takes part in intracellular proteolysis in specific tissues and cells during physiological conditions.

Entities:  

Keywords:  MMP-2; gelatinolytic activity; homeostasis; intracellular

Mesh:

Substances:

Year:  2013        PMID: 23482328      PMCID: PMC3715330          DOI: 10.1369/0022155413484765

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  45 in total

1.  The role of fibroblasts in the remodeling of periodontal ligament during physiologic tooth movement.

Authors:  A R Ten Cate; D A Deporter; E Freeman
Journal:  Am J Orthod       Date:  1976-02

2.  Self-organization of engineered epithelial tubules by differential cellular motility.

Authors:  Hidetoshi Mori; Nikolce Gjorevski; Jamie L Inman; Mina J Bissell; Celeste M Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-18       Impact factor: 11.205

3.  Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.

Authors:  A Ginestra; S Monea; G Seghezzi; V Dolo; H Nagase; P Mignatti; M L Vittorelli
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

Review 4.  Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease.

Authors:  Mohammad A M Ali; Xiaohu Fan; Richard Schulz
Journal:  Trends Cardiovasc Med       Date:  2011-05       Impact factor: 6.677

5.  Vitamin D regulation of metalloproteinase activity in matrix vesicles.

Authors:  D D Dean; Z Schwartz; J Schmitz; O E Muniz; Y Lu; F Calderon; D S Howell; B D Boyan
Journal:  Connect Tissue Res       Date:  1996       Impact factor: 3.417

6.  Serum is a rich source of ligands for the scavenger receptor of hepatic sinusoidal endothelial cells.

Authors:  Berit Hansen; Jukka Melkko; Bård Smedsrød
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

7.  Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.

Authors:  Miranda M Sung; Christina G Schulz; Wenjie Wang; Grzegorz Sawicki; Norma L Bautista-López; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2007-07-31       Impact factor: 5.000

8.  Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.

Authors:  Jennifer A Kwan; Costas J Schulze; Wenjie Wang; Hernando Leon; Meltem Sariahmetoglu; Miranda Sung; Jolanta Sawicka; David E Sims; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2004-02-06       Impact factor: 5.191

9.  Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.

Authors:  Suvi-Tuuli Vilen; Pia Nyberg; Mika Hukkanen; Meeri Sutinen; Merja Ylipalosaari; Anders Bjartell; Annukka Paju; Virpi Haaparanta; Ulf-Håkan Stenman; Timo Sorsa; Tuula Salo
Journal:  Exp Cell Res       Date:  2007-11-12       Impact factor: 3.905

10.  Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation.

Authors:  Bon-Hun Koo; Yeon Hyang Kim; Jung Ho Han; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

View more
  5 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  MMP-2 and Notch signal pathway regulate migration of adipose-derived stem cells and chondrocytes in co-culture systems.

Authors:  Qi Zhang; Shuwen Deng; Ke Sun; Shiyu Lin; Yunfeng Lin; Bofeng Zhu; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2017-09-18       Impact factor: 6.831

Review 3.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

4.  Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein.

Authors:  Haein Lee; Geunhwa Park; Seulha Kim; Boram Son; Jinmyoung Joo; Hee Ho Park; Tai Hyun Park
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-13       Impact factor: 5.560

5.  MMP9 polymorphism is associated with susceptibility to non-traumatic osteonecrosis of femoral head in a Chinese Han population.

Authors:  Yuan Liu; Yanfei Jia; Yuju Cao; Yan Zhao; Jieli Du; Feimeng An; Yuxin Qi; Xue Feng; Tianbo Jin; Jianping Shi; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.